ZA-17 5mg
Pill imprint ZA-17 5mg has been identified as Bromocriptine mesylate 5 mg.
Bromocriptine is used in the treatment of hyperprolactinemia; diabetes, type 2; parkinson's disease; acromegaly; tardive dyskinesia and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy.
Bromocriptine 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Bromocriptine mesylate Images
- Imprint:
-
ZA-17
5mg - Strength:
- 5 mg
- Color:
- Tan & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
Prolactin inhibitors - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Zydus Pharmaceuticals
Advertisement
More Bromocriptine Mesylate resources
- Bromocriptine (Wolters Kluwer)
- Bromocriptine Mesylate (Wolters Kluwer)
- bromocriptine (Cerner Multum)
- bromocriptine (Micromedex) - Includes Dosage Information
- Bromocriptine Mesylate (AHFS DI)
- Bromocriptine (FDA)
- Bromocriptine Capsules (FDA)
- Bromocriptine Mesylate (Wolters Kluwer)
Search Again
